HF
MXCT icon

HRT Financial’s MaxCyte MXCT Stock Holding History

HRT Financial’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Buy
121,204
+92,404
+321% +$92.1K ﹤0.01% 3497
2026
Q1 		$20K Sell
28,800
-99,912
-78% -$93.3K ﹤0.01% 3574
2025
Q4 		$199K Buy
+128,712
New +$206K ﹤0.01% 2640
2025
Q3 		– Sell
-37,497
Closed -$81K – 3389
2025
Q2 		$81K Buy
37,497
+20,595
+122% +$49.9K ﹤0.01% 2241
2025
Q1 		$46K Sell
16,902
-109,343
-87% -$431K ﹤0.01% 2246
2024
Q4 		$525K Buy
+126,245
New +$477K ﹤0.01% 1412
2023
Q2 		– Sell
-16,883
Closed -$83K – 2974
2023
Q1 		$83K Buy
+16,883
New +$83.1K ﹤0.01% 2086

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

HRT Financial's MXCT Position: Q2 2026 in Review

HRT Financial increased its MaxCyte (MXCT) stake by 321% in Q2 2026, buying an estimated $92.1K and bringing the position to 121,204 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #3497.

HRT Financial first reported a position in MXCT in Q1 2023 and has held it in 7 quarters since. The position peaked at $525K in Q4 2024. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • HRT Financial held 121,204 shares of MaxCyte worth $149K as of Q2 2026.
  • HRT Financial bought 92,404 MaxCyte shares in Q2 2026, an estimated $92.1K.
  • MaxCyte made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3497 holding.
  • HRT Financial first reported a position in MaxCyte in Q1 2023 and has held it in 7 quarters since.
  • HRT Financial's MaxCyte position peaked at $525K in Q4 2024.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.